Regulatory & Compliance Support for Federal Pharmaceutical Sales

The contract entails providing comprehensive regulatory and compliance support for federal pharmaceutical sales, specifically focusing on adherence to FDA and DEA requirements alongside federal contracting standards. This includes the preparation, maintenance, and certification of all necessary documentation to ensure full compliance with applicable laws and regulations governing the distribution and sale of pharmaceuticals within federal programs. The scope requires expert knowledge of federal procurement rules and pharmaceutical regulations to facilitate seamless operations and audit readiness for the Department of Defense via the Defense Logistics Agency. This is a subcontract under the NAICS code 541611, indicating it involves administrative management and general management consulting services related to regulatory affairs. The contract is linked to the federal award SPE2D926F8115 and was posted on August 9, 2026, with performance expected to support DLA’s mission-critical pharmaceutical supply chain. There is no specific set-aside designation noted, and the place of performance is not defined, suggesting the work may be performed remotely or across multiple locations as needed to meet federal compliance obligations.